VISAGGI, PIERFRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.625
AS - Asia 2.077
EU - Europa 1.049
SA - Sud America 301
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 74
OC - Oceania 4
Totale 8.256
Nazione #
US - Stati Uniti d'America 4.465
SG - Singapore 888
CN - Cina 483
IT - Italia 427
BR - Brasile 239
HK - Hong Kong 235
VN - Vietnam 139
DE - Germania 104
GB - Regno Unito 103
CA - Canada 96
SE - Svezia 74
FR - Francia 60
IN - India 59
AT - Austria 58
FI - Finlandia 52
KR - Corea 49
JP - Giappone 48
NL - Olanda 37
RU - Federazione Russa 37
BD - Bangladesh 30
MX - Messico 24
ES - Italia 22
CI - Costa d'Avorio 21
AR - Argentina 19
IQ - Iraq 17
PL - Polonia 17
TR - Turchia 16
SA - Arabia Saudita 15
ZA - Sudafrica 15
ID - Indonesia 14
PK - Pakistan 13
IL - Israele 12
LT - Lituania 12
EC - Ecuador 10
VE - Venezuela 10
IR - Iran 9
MA - Marocco 8
SC - Seychelles 8
CO - Colombia 7
PT - Portogallo 7
UA - Ucraina 7
CR - Costa Rica 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
DZ - Algeria 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
PE - Perù 5
AU - Australia 4
EE - Estonia 4
GT - Guatemala 4
IE - Irlanda 4
KE - Kenya 4
LB - Libano 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GP - Guadalupe 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
BB - Barbados 2
BH - Bahrain 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HU - Ungheria 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BE - Belgio 1
BJ - Benin 1
BS - Bahamas 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
MD - Moldavia 1
Totale 8.125
Città #
Ashburn 592
San Jose 523
Singapore 519
Santa Clara 235
Hong Kong 231
Dallas 220
Los Angeles 122
Shanghai 109
Council Bluffs 87
Beijing 75
Hefei 70
Boardman 67
New York 54
Atlanta 53
Seoul 49
Vienna 49
Ho Chi Minh City 43
Munich 43
Tokyo 43
Lucca 37
Hanoi 36
London 35
Milan 33
São Paulo 33
Helsinki 31
Denver 28
Orem 28
Buffalo 25
Phoenix 25
Rome 25
Brooklyn 24
Chicago 23
Frankfurt am Main 23
Abidjan 21
Princeton 21
Florence 20
Montreal 20
Chandler 19
North Bergen 18
Hyderabad 17
Redondo Beach 17
Turku 15
Chennai 14
Houston 14
Lauterbourg 14
Nuremberg 14
San Francisco 14
Toronto 14
Warsaw 14
Fuzhou 13
Mantova 13
Pisa 13
Düsseldorf 12
Seattle 12
Baltimore 11
Bologna 11
Mexico City 10
Philadelphia 9
Poplar 9
Johannesburg 8
Memphis 8
Palermo 8
Belo Horizonte 7
Fairfield 7
Haiphong 7
Manchester 7
Stockholm 7
Abbeville 6
Amsterdam 6
Baghdad 6
Casablanca 6
Dhaka 6
Lappeenranta 6
Las Vegas 6
New Delhi 6
Ogden 6
Riyadh 6
Tashkent 6
Washington 6
Brasília 5
Columbus 5
Genoa 5
Lawrence 5
Madrid 5
Miami 5
Rio de Janeiro 5
Salt Lake City 5
San Diego 5
San José 5
The Bronx 5
Vilnius 5
Wilmington 5
Winnipeg 5
Amman 4
Baku 4
Birmingham 4
Bogotá 4
Boston 4
Can Tho 4
Cleveland 4
Totale 4.198
Nome #
Italian guidelines for the diagnosis and treatment of functional dyspepsia - joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG) 492
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 357
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease Severity 323
Efficacy of Dupilumab for Induction and Maintenance of Remission in Patients With Eosinophilic Gastritis, Enteritis, and Colitis With Concomitant Eosinophilic Esophagitis 276
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 254
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study 249
The Revised Reflux Symptom Index (R-RSI): Development, Internal and External Validation Study 246
The Esophageal Mucosa: Clues to Underlying Pathology 206
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 199
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 189
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 186
Letter: Peripheral Blood Eosinophils as Complementary Biomarkers for Diagnosis and Follow‐Up in Eosinophilic Oesophagitis—Authors' Reply 179
Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS 177
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 177
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 169
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications 163
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 160
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis - Definition, Clinical Presentation and Diagnosis 160
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis-Current Treatment and Monitoring 153
Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice 139
Modern diagnosis of early esophageal cancer: From blood biomarkers to advanced endoscopy and artificial intelligence 132
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction 131
Dietary management of eosinophilic esophagitis: Tailoring the approach 130
Adaptive Behaviors, Esophageal Anxiety and Hypervigilance Modify the Association Between Dysphagia Perception and Histological Disease Activity in Eosinophilic Esophagitis 127
Robotic Colonoscopy and Beyond: Insights into Modern Lower Gastrointestinal Endoscopy 119
Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care Use 119
Systematic review with meta-analysis: artificial intelligence in the diagnosis of oesophageal diseases 119
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 117
Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms - A multicentre retrospective study 114
Efficacy of a Second PPI Course After Steroid-Induced Remission in Eosinophilic Esophagitis Refractory to Initial PPI Therapy 110
The Milan Score is an Effective Manometric Tool to Predict Gastroesophageal Reflux in Patients With Laryngopharyngeal Symptoms 103
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 101
Assessment of Esophagogastric Junction Barrier Function With the Supine‐Upright Transition of the Chicago Classification Protocol 96
Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease 96
The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux disease 93
Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis 90
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction 89
Nutrient Composition of Four Dietary Patterns in Italy: Results from an Online Survey (the INVITA Study) 89
Bone mineral density parameters and related nutritional factors in vegans, lacto-ovo-vegetarians, and omnivores: a cross-sectional study 85
Systematic Review: Use of Artificial Intelligence and Unmet Needs in Eosinophilic Oesophagitis 82
Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components 82
THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0 THAT ASSOCIATES WITH TREATMENT OUTCOME FROM ANTI-REFLUX THERAPY 81
Nutrition in gastroenterology: Rising evidence and future directions 79
Esophageal motility disorders among elderly patients: An international multicenter study 77
Plant-based diets in gastrointestinal diseases: Which evidence? 75
Six-Food Elimination Diet Is Less Effective During Pollen Season in Adults With Eosinophilic Esophagitis Sensitized to Pollens 73
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review 72
The AFS Endoscopic Classification of Esophago-Gastric Junction Integrity is Superior to the Hill Classification in Terms of Interobserver Variability 71
Author's reply: "The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis and the missing link: Helicobacter pylori infection" 70
Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis 69
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' 67
Clinical Characteristics, Endoscopic Findings, and Treatment Outcomes in Lymphocytic Esophagitis Compared to Eosinophilic Esophagitis 64
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials 61
Improving the Diagnostic Yield of High-Resolution Esophageal Manometry for GERD: The "Straight Leg-Raise" International Study 60
Rapid Drink Challenge During High-resolution Manometry for Evaluation of Esophageal Emptying in Treated Achalasia 51
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults 51
Esophageal motor disorders across ages: A retrospective multicentric analysis 50
How safe are heartburn medications and who should use them? 46
Efficacy of dupilumab in patients with prior exposure to topical steroids: facing second-line treatments for eosinophilic oesophagitis 46
Effect of hiatus hernia on reflux patterns and mucosal integrity in patients with non-erosive reflux disease 45
Updated treatment options for gastroesophageal reflux disease in children: practical guide for clinician 45
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 43
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes 39
Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi-Centre Study 36
Esophageal motility disorders in the elderly: supporting diagnostic integrity and future research directions 35
Emerging innovation, artificial intelligence, and digital technology in esophagology 33
Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment 33
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis 31
The conundrum of esophagogastric junction outflow obstruction: Answers to key clinical questions 30
Optimizing the Straight Leg Raise Maneuver to Improve Prediction of Conclusive Gastro-Esophageal Reflux Disease 30
null 15
Totale 8.256
Categoria #
all - tutte 20.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.023


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 0 6 7 4 2 3 3 5 9
2022/2023151 9 16 18 10 9 34 1 9 32 2 4 7
2023/2024191 11 13 13 19 10 7 28 1 3 16 28 42
2024/20251.789 54 42 94 94 119 175 128 79 181 137 248 438
2025/20263.204 174 281 267 335 369 237 413 164 192 430 219 123
2026/20272.861 351 984 359 1.018 149 0 0 0 0 0 0 0
Totale 8.256